Levopropranolol

Levopropranolol

SCHEMBL41689

CC(C)NC[C@H](O)COc1cccc2ccccc12.Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2

The experimentally established mechanism targets of Levopropranolol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 known ✓ P07550 8/20 1.00
ADRB1 known ✓ P08588 7/20 1.00
ADRB3 P13945 6/20 1.00
SIGMAR1 Q99720 4/20 1.00
ALDH1A1 P00352 4/20 1.00
HTR2C P28335 4/20 1.00
LMNA P02545 4/20 1.00
HTR1A P08908 4/20 1.00
HTR2A P28223 3/20 1.00
HTR6 P50406 3/20 1.00
TSHR P16473 3/20 1.00
MAPK1 P28482 3/20 1.00
PMP22 Q01453 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
BLM P54132 2/20 1.00
TMEM97 Q5BJF2 2/20 1.00
APEX1 P27695 1/20 1.00
TDP1 Q9NUW8 1/20 1.00
CYP2D6 P10635 6/20 0.97
NR2E1 Q9Y466 5/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propranolol SCHEMBL9064508 1.00 ADRB2 (1.00) ADRB2ADRB1ADRB3SIGMAR1ALDH1A1
Propranolol SCHEMBL29349844 1.00 ADRB2 (1.00) ADRB2ADRB1ADRB3SIGMAR1ALDH1A1
Dexpropranolol SCHEMBL610656 1.00 ADRB2 (1.00) ADRB2ADRB1ADRB3SIGMAR1ALDH1A1
Propranolol SCHEMBL17838091 1.00 ADRB2 (1.00) ADRB2ADRB1ADRB3SIGMAR1ALDH1A1
Propranolol SCHEMBL41688 1.00 ADRB2 (1.00) ADRB2ADRB1ADRB3SIGMAR1ALDH1A1
Propranolol SCHEMBL1553064 1.00 ADRB2 (1.00) ADRB2ADRB1ADRB3SIGMAR1ALDH1A1
Dexpropranolol SCHEMBL30309315 1.00 ADRB2 (1.00) ADRB2ADRB1ADRB3SIGMAR1ALDH1A1
Levopropranolol SCHEMBL30530984 1.00 ADRB2 (1.00) ADRB2ADRB1ADRB3SIGMAR1ALDH1A1
Propranolol SCHEMBL9183224 0.99 ADRB2 (0.97) ADRB2ADRB1ADRB3SIGMAR1ALDH1A1
Propranolol SCHEMBL7397696 0.99 ADRB2 (0.97) ADRB2ADRB1ADRB3SIGMAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 13006 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260076872-A1 POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME SIO2 MEDICAL PRODUCTS LLC (US) 2026-03-19 US claimed
EP-4709378-A1 COMPOUNDS FOR NOS-RELATED CANCERS AND METHODS OF USE Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) 2026-03-18 EP claimed
EP-4687837-A1 AN ORALLY RAPIDLY DISINTEGRATING TABLET OF PROPRANOLOL AND ITS PROCESS OF PREPARATION Novumgen Limited (GB) 2026-02-11 EP claimed
EP-4691556-A2 HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF H. Lundbeck A/S (DK) 2026-02-11 EP claimed
US-20250387343-A1 Nanoparticle Compositions and Methods for Synthesis Thereof ICEUTICA PTY LTD (AU) 2025-12-25 US claimed
US-20250264469-A1 METHODS FOR IMPROVING OUTCOMES FOR HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS AT RISK FOR BRONCHIOLITIS OBLITERANS SYNDROME CHILDREN'S HOSPITAL MEDICAL CENTER 2025-08-21 US claimed
US-20250242046-A1 ALLOGENEIC HYPOIMMUNE BIOMIMETIC NANOVESICLE FOR THE TREATMENT OF CANCER MALCOLM THOMAS (US) 2025-07-31 US claimed
US-20250242092-A1 SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS SIO2 MEDICAL PRODUCTS INC (US) 2025-07-31 US claimed
EP-4565222-A1 MODIFIED-RELEASE ALGINATE-BASED COMPOSITION Nutrition & Biosciences USA 1, LLC (US) 2025-06-11 EP claimed
US-20250169715-A1 USE OF BLINK REFLEX FOR HEADACHE RESPONSE MONITORING AND/OR TREATMENT SELECTION BLINKTBI INC (US) 2025-05-29 US claimed
US-4443428-A PARAFFIN WAXES, ALCOHOLS, FREE BASE AND SALT MIXTURES EUROCELTIQUE, S.A. (LU) 1984-04-17 US claimed
US-4394390-A Nasal dosage forms of propranol UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 1983-07-19 US claimed
US-4309405-A Sustained release pharmaceutical compositions AMERICAN HOME PRODUCTS CORPORATION (US) 1982-01-05 US claimed
US-4309404-A CORE CONTAINING A DRUG, SEAL COATING, SUGAR OVERCOATING AMERICAN HOME PRODUCTS CORPORATION (US) 1982-01-05 US claimed
US-4309406-A CORE CONTAINING A DRUG, SEAL COATING, SUGAR OVERCOATING AMERICAN HOME PRODUCTS CORPORATION (US) 1982-01-05 US claimed
EP-0023704-A2 Novel dosage forms containing propanolol The University of Kentucky Research Foundation (US) 1981-02-11 EP claimed
US-4248857-A PROPRANOLOL AND SUGAR COATING ON A CORE OF PROPRANOLOL, POLYACRYLIC ACID, STEARIC ACID AND MANNITOL; ENERGIC BLOCKING AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 1981-02-03 US claimed
US-4248858-A COMPRISING A CORE OF PROPRANOLOL, A CELLULOSE DERIVATIVE AND ETHYL CELLULOSE, AN ENTERIC COATING AND A SUGAR COATING CONTAINING PROPRANOLOL AMERICAN HOME PRODUCTS CORPORATION (US) 1981-02-03 US claimed
US-4248856-A COMPRISING A CELLULOSIC CORE, SUGAR COATING AND HAVING PROPRANOLOL IN BOTH AMERICAN HOME PRODUCTS CORPORATION (US) 1981-02-03 US claimed
US-4138475-A Sustained release pharmaceutical composition IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1979-02-06 US claimed